Chronic Cannabinoid Treatment Produced Antidepressant Effects in Male and Female Rats
Ten days of cannabinoid receptor activation produced antidepressant-like effects in rats of both sexes through a noradrenergic mechanism, which were reversed when withdrawal was precipitated.
Quick Facts
What This Study Found
Male rats received the CB1 receptor agonist HU-210 for 10 days and then underwent the forced swim test, a standard measure of depressive-like behavior.
HU-210 reduced immobility and increased struggling, matching the effects of the antidepressant desipramine. This effect was blocked by both alpha- and beta-adrenergic receptor antagonists, indicating the antidepressant response involves the noradrenergic (norepinephrine) system.
The same effect occurred in both male and female rats, demonstrating it is not sex-specific.
When the CB1 antagonist AM251 was given before the test (precipitating withdrawal), the antidepressant effect was eliminated, confirming it depends on ongoing cannabinoid receptor activation rather than being a lasting neuroadaptation.
Key Numbers
HU-210 dose: 0.1 mg/kg for 10 days. Desipramine: 10 mg/kg. Prazosin (alpha1 blocker) at 1 mg/kg and propranolol (beta blocker) at 2.5 mg/kg both attenuated the antidepressant effect. Effect present in both sexes.
How They Did This
Three experiments using the forced swim test in rats. Experiment 1: 10-day HU-210 vs desipramine vs vehicle. Experiment 2: Same protocol with noradrenergic antagonists to test mechanism. Experiment 3: Males and females, with CB1 antagonist AM251 to test withdrawal effects.
Why This Research Matters
This study identified a specific mechanism (noradrenergic involvement) through which cannabinoid receptor activation produces antidepressant effects, and showed the effect is present in both sexes but dependent on continued receptor activation.
The Bigger Picture
The relationship between cannabis and depression is complex. This study suggests that sustained cannabinoid receptor activation can produce antidepressant-like effects through a defined mechanism, but withdrawal eliminates these effects, which has implications for understanding mood changes during cannabis cessation.
What This Study Doesn't Tell Us
The forced swim test is a limited model of human depression. HU-210 is a synthetic cannabinoid much more potent than THC. The finding that withdrawal reversed the effect raises questions about therapeutic utility. Animal depression models have significant limitations.
Questions This Raises
- ?Would THC produce similar antidepressant effects through the noradrenergic system?
- ?Does the withdrawal reversal explain why some people experience depression when stopping cannabis?
- ?Could this mechanism be exploited therapeutically without creating dependence?
Trust & Context
- Key Stat:
- Cannabinoid antidepressant effect matched desipramine and was blocked by noradrenergic antagonists
- Evidence Grade:
- Well-controlled preclinical study identifying a specific mechanism, but using a potent synthetic cannabinoid and an animal model of depression with known limitations.
- Study Age:
- Published in 2009. The relationship between cannabinoids and depression continues to be studied, with complex and sometimes contradictory findings in human populations.
- Original Title:
- Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.
- Published In:
- Physiology & behavior, 98(1-2), 118-24 (2009)
- Authors:
- Morrish, Anna C, Hill, Matthew N(19), Riebe, Caitlin J N, Gorzalka, Boris B
- Database ID:
- RTHC-00375
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does this mean cannabis is an antidepressant?
This study found antidepressant-like effects from a potent synthetic cannabinoid in rats. However, the effect was lost during withdrawal, which means stopping use could reverse any mood benefits. Human data on cannabis and depression are much more complex and mixed.
Why was the effect eliminated by withdrawal?
The antidepressant effect required ongoing CB1 receptor activation. When the receptor was blocked (mimicking withdrawal), the effect disappeared, suggesting the mood improvement depends on continued cannabinoid signaling rather than lasting brain changes.
Read More on RethinkTHC
- LGBTQ-cannabis-use-recovery-support
- cannabis-induced-psychosis
- online-therapy-cannabis-anxiety-review
- quitting-weed-adhd
- quitting-weed-depression
- quitting-weed-ptsd
- self-medicating-with-weed
- weed-OCD-intrusive-thoughts
- weed-and-ptsd
- weed-childhood-trauma-ACE
- weed-suicidal-thoughts-withdrawal
- thc-and-ssris-cannabis-antidepressants
Cite This Study
https://rethinkthc.com/research/RTHC-00375APA
Morrish, Anna C; Hill, Matthew N; Riebe, Caitlin J N; Gorzalka, Boris B. (2009). Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.. Physiology & behavior, 98(1-2), 118-24. https://doi.org/10.1016/j.physbeh.2009.04.023
MLA
Morrish, Anna C, et al. "Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.." Physiology & behavior, 2009. https://doi.org/10.1016/j.physbeh.2009.04.023
RethinkTHC
RethinkTHC Research Database. "Protracted cannabinoid administration elicits antidepressant..." RTHC-00375. Retrieved from https://rethinkthc.com/research/morrish-2009-protracted-cannabinoid-administration-elicits
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.